Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2014, Vol. 34 Issue (4): 27-35    DOI: 10.13523/j.cb.20140405
    
The Effect of Insulin Receptor Substrates 1 and 2 Knockdown on Porcine Hepatic Glucolipid Metabolism
HUANG Tian-qing1, KONG Qing-ran1, LI Yan1, YU Miao2, LIU Zhong-hua1
1. Laboratory of Embryo Engineering, Department of Life Science, Northeast Agricultural University, Harbin 150030, China;
2. Harbin Power Vocational Technology College, Harbin 150030, China
Download: HTML   PDF(1398KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

Objective: Through efficient shRNA interference to knockdown simultaneously IRS1 and IRS2 in porcine liver cells, and verify its effects on genes expression related to glucolipid metabolism, which may lay a solid foundation for producing the type2 diabetes mellitus model pigs. Method: First of all, cloning porcine IRS1 gene and the partial 3-untranslated region sequence of IRS2 gene by Overlap PCR and 3'RACE respectively. Then screening the most effective interference shRNA fragments of IRS1 and IRS2 by Real-time PCR. Finally, the glucolipid metabolism related genes experssion were detected in the porcine liver cells of both knocking down IRS1 and IRS2. Result: The knockdown of both IRS1 and IRS2 resulted in significant upregulation of gluconeogenic enzymes PEPCK and F-1,6-BP, as well as a decrease in Gck expression, at the same time, also led to the upregulation of lipogenic enzymes SREBP-1, Abcg8 and CYP7a1. Conclusion: The knockdown of both IRS1 and IRS2 may lead to an increasing level of blood glucose and also can cause a disorder of cholesterol metabolism. Therefore, IRS1 and IRS2 have important roles in the regulation of hepatic glucolipid metabolism.



Key wordsIRS1      IRS2      RNA interference      Glucolipid metabolism      Pig     
Received: 02 January 2014      Published: 25 April 2014
ZTFLH:  Q819  
Cite this article:

HUANG Tian-qing, KONG Qing-ran, LI Yan, YU Miao, LIU Zhong-hua. The Effect of Insulin Receptor Substrates 1 and 2 Knockdown on Porcine Hepatic Glucolipid Metabolism. China Biotechnology, 2014, 34(4): 27-35.

URL:

https://manu60.magtech.com.cn/biotech/10.13523/j.cb.20140405     OR     https://manu60.magtech.com.cn/biotech/Y2014/V34/I4/27


[1] Zimmet P, Alberti K G, Shaw J, Global and societal implications of the diabetes epidemic. Nature, 2001, 414(6865):782-787.

[2] Kadowaki T, Miyake Y, Hagura R. Risk factors for worsening to diabetes in subjects with impaired glucose tolerance. Diabetologia, 1984, 26(1):44-49.

[3] Moller D E. Transgenic approaches to the pathogenesis of NIDDM. Diabetes, 1994, 43(12):1394-1401.

[4] White M F, Kahn C R. The insulin signaling system. J Biol Chem, 1994, 269(1):1-4.

[5] Kido Y, et al. Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2. J Clin Invest, 2000, 105(2):199-205.

[6] Araki E, et al. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature, 1994, 372(6502):186-190.

[7] Tamemoto H, et al. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature, 1994, 372(6502):182-186.

[8] Withers D J, et al. Disruption of IRS-2 causes type 2 diabetes in mice. Nature, 1998, 391(6670):900-904.

[9] Withers D J, et al. Irs-2 coordinates Igf-1 receptor-mediated beta-cell development and peripheral insulin signalling. Nat Genet, 1999, 23(1):32-40.

[10] Hasty A H, et al. Severe hypercholesterolemia, hypertriglyceridemia, and atherosclerosis in mice lacking both leptin and the low density lipoprotein receptor. J Biol Chem, 2001, 276(40):37402-37408.

[11] Schook L, et al. Swine in biomedical research: creating the building blocks of animal models. Anim Biotechnol, 2005, 16(2):183-190.

[12] von Wilmowsky C, et al., Establishment of a streptozotocin induced diabetic domestic pig model and a systematic evaluation of pathological changes in the hard and soft tissue over a 12-month period. Clin Oral Implants Res, 2010, 21(7):709-717.

[13] Renner S, et al. Glucose intolerance and reduced proliferation of pancreatic beta-cells in transgenic pigs with impaired glucose-dependent insulinotropic polypeptide function. Diabetes, 2010, 59(5):1228-1238.

[14] Farrell G C, et al.Research workshop: techniques for primary culture of liver cells. J Gastroenterol Hepatol,1998,13:842.

[15] Zhang C K, Lin W, Cai Y N. Characterization of the genomic structure and tissue-specific promoter of the human nuclear receptor NR5A2 (hB1F) gene. Gene, 2001, 273(2): 239-249.

[16] Niu P X, Huang Z, Li C C. Cloning, chromosomal localization, SNP detection and association analysis of the porcine IRS-1 gene. Mol Biol Rep, 2009, 36(8):2087-2092.

[17] Kerouz N J, Horsch D, Pons S. Differential regulation of insulin receptor substrates-1 and -2 ( IRS-1 and IRS-2) and phosphatidylinositol 3-kinase isoforms in liver and muscle of the obese diabetic (ob/ob) mouse. J Clin Invest, 1997, 100(12):3164-3172.

[18] Gribble F M. Metabolism: a higher power for insulin. Nature, 2005, 434(7036):965-966.

[19] Taniguchi C M, Ueki K, Kahn R. Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism. J Clin Invest, 2005, 115(3):718-727.

[20] Fisher S J, Kahn C R. Insulin signaling is required for insulin's direct and indirect action on hepatic glucose production. J Clin Invest, 2003, 111(4):463-468.

[1] YANG Wan-bin,XU Yan,ZHUO Shi-xuan,WANG Xin-yi,LI Ya-jing,GUO Yi-fan,ZHANG Zheng-guang,GUO Yuan-yuan. Progress of Long Non-coding RNAs Related Epigenetic Modifications in Cancer[J]. China Biotechnology, 2021, 41(8): 59-66.
[2] FENG Zhao,LI Jiang-hao,WANG Jia-hua. Functional Analysis of RpRPL22, a Ribosomal Protein Homologous Gene, in the Symbiotic Nodulation Process of Robinia Pseudoacacia[J]. China Biotechnology, 2021, 41(7): 10-21.
[3] YAN Yu-jia,ZOU Ling. Research Progress on the Biogenesis and Function of piRNAs[J]. China Biotechnology, 2021, 41(5): 45-50.
[4] Yu CHENG,Qiong SHI,Li-qin AN,Meng-tian FAN,Gai-gai HUANG,Ya-guang WENG. BMP7 Gene Silencing Inhibits Osteogenic Differentiation of Porcine Arotic Valve Interstitial Cells Induced by Osteogenic Induction Medium[J]. China Biotechnology, 2019, 39(5): 63-71.
[5] Jun-song SHI,Lü-hua LUO,Rong ZHOU,Ran-biao MAI,Hong-mei JI,Wan-xian YU,Zhen-fang WU,Geng-yuan CAI. Delayed Activation Can Improve in Vitro and in Vivo Developmental Capacity of Pig Cloned Embryos[J]. China Biotechnology, 2019, 39(4): 16-23.
[6] Zhao FENG,Min-xia CHOU. Functional Analysis of Rpfan37 in the Symbiotic Nodulation Process of Robinia Pseudoacacia[J]. China Biotechnology, 2018, 38(5): 47-55.
[7] DONG Wei-peng,ZHANG Shao-hua,XU Xiang,YAN Jiong. The Effect and Mechanism of Down-Regulated Fsp27 Gene Combined with Myricetin on Lipolysis of 3T3-L1 Adipocytes[J]. China Biotechnology, 2018, 38(12): 7-13.
[8] MENG Ying-ying, YAO Chang-hong, LIU Jiao, SHEN Pei-li, XUE Song, YANG Qing. Review and Evaluation of Microalgal Components Determination Methods[J]. China Biotechnology, 2017, 37(7): 133-143.
[9] LIU Yi-xuan, BIAN Zhen, MA Hong-mei. Progress and Prospect of Cancer Gene Therapy[J]. China Biotechnology, 2016, 36(5): 106-111.
[10] HU Na, LIU Qing, TANG Zhao-yong, TANG He-jing, AO Lan, ZHAO Zi-hao, FANG Liao-qiong. siRNA Inhibits the Growth and Migration of Mouse Melanoma by MMP-9 and FAK Gene[J]. China Biotechnology, 2016, 36(5): 34-39.
[11] ZHAO Zhi-wu, WANG Jun-shi, MA Min, ZHANG Shao-hua, YAN Jiong. Effect of Down-regulated Perilipin 1 Gene Expression on Lipolysis of 3T3-L1 Adipocytes[J]. China Biotechnology, 2016, 36(3): 17-22.
[12] DAI Yu huan, XU Yao, LUO Ying, DAI Yang, SHI Wei lin, XU Yao. The Transcriptional Regulation of Ca2+ Channel Mediated by Myocardin in H9C2 Cell[J]. China Biotechnology, 2016, 36(11): 1-6.
[13] WU Meng, LIU Zuo-hua, LIN Bao-zhong, LAN Guo-cheng, ZOU Xian-gang, GE Liang-peng. Recent Progress in Transgenic Pigs[J]. China Biotechnology, 2015, 35(3): 92-98.
[14] XUE Yu-wen, LI Tie-jun, ZHOU Jia-ming, CHEN Li. The Application and Perspectives of Multi-target RNAi in the Research and Development of Gene Therapy[J]. China Biotechnology, 2015, 35(1): 75-81.
[15] SU Lan, ZHANG Ping, WANGYANG Jun-qi, ZHONG Ru-gang. Progress on the Inhibition of Hepatitis B virus by siRNA Strategy[J]. China Biotechnology, 2014, 34(9): 102-107.